Hikma's Advair Generic Gets Further Delayed Post author:Sam Post published:March 11, 2018 Post category:BioPharma Hikma Pharmaceuticals generic version of Advair has hit a stumbling block with the FDA. Source: BioSpace You Might Also Like 9 Reasons to Buy Pfizer in 2018 and 1 Big One Not To December 21, 2017 Shareholders Turn Down Tender Offer to Take BioCanCell Private December 27, 2017 Tekni-Plex Begins Production At New China Manufacturing Facility August 28, 2017
